Skip to content

Clinical trials

Completed Phase 1/2 Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 1/2 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20112
20121
20151
20162
20172
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Herantis Pharma Plc.2
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud1
BBB-Therapeutics B.V.1
Banc de Sang i Teixits1
BeiGene USA, Inc.1
Catabasis Pharmaceuticals1
King Saud University1
LYSOGENE1
National Institute of Mental Health (NIMH)1
TVAX Biomedical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases12
Brain Diseases4
Brain Neoplasms3
Central Nervous System Neoplasms3
Neoplasms3
Astrocytoma2
Autoimmune Diseases2
Central Nervous System Diseases2
Demyelinating Diseases2
Glioblastoma2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.